Article info
PDFNeurodegeneration
Research paper
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
- Correspondence to Dr Jeffrey Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health, 888 W. Bonneville Avenue, Las Vegas, NV 89106, USA; cumminj{at}ccf.org
Citation
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
Publication history
- Received October 1, 2015
- Revised February 19, 2016
- Accepted February 29, 2016
- First published March 23, 2016.
Online issue publication
August 12, 2016
Article Versions
- Previous version (12 August 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/